Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ads Free, Unlimited access)​
NO CREDIT CARD REQUIRED
PHG logo

Koninklijke Philips NV ADR (PHG)PHG

Upturn stock ratingUpturn stock rating
Koninklijke Philips NV ADR
$30.87
Delayed price
Profit since last BUY8.62%
Consider higher Upturn Star rating
upturn advisory
BUY since 36 days
  • BUY Advisory
  • Profitable SELL
  • Loss-Inducing SELL
  • Profit
  • Loss ​
  • PASS (Skip invest)*​ ​
Upturn Stock price based out of last closeUpturn Stock price based out of last close Stock price based out of last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK
Time period over

Upturn Advisory Summary

09/18/2024: PHG (2-star) has a low Upturn Star Rating. Not recommended to BUY.

Analysis of Past Upturns

Type: Stock
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Today’s Advisory: Consider higher Upturn Star rating
Profit: 27.28%
Upturn Advisory Performance Upturn Advisory Performance4
Avg. Invested days: 38
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Stock Returns Performance Upturn Returns Performance 3
Last Close 09/18/2024
Type: Stock
Today’s Advisory: Consider higher Upturn Star rating
Profit: 27.28%
Avg. Invested days: 38
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Stock Returns Performance Upturn Returns Performance 3
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 09/18/2024
Upturn Advisory Performance Upturn Advisory Performance4

Key Highlights

Company Size Large-Cap Stock
Market Capitalization 29.07B USD
Price to earnings Ratio -
1Y Target Price 28.37
Dividends yield (FY) -
Basic EPS (TTM) -0.65
Volume (30-day avg) 744275
Beta 0.72
52 Weeks Range 17.16 - 31.50
Updated Date 09/18/2024
Company Size Large-Cap Stock
Market Capitalization 29.07B USD
Price to earnings Ratio -
1Y Target Price 28.37
Dividends yield (FY) -
Basic EPS (TTM) -0.65
Volume (30-day avg) 744275
Beta 0.72
52 Weeks Range 17.16 - 31.50
Updated Date 09/18/2024

Earnings Date

Report Date -
When -
Estimate -
Actual -
Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -2.32%
Operating Margin (TTM) 6.23%

Management Effectiveness

Return on Assets (TTM) 1.36%
Return on Equity (TTM) -4.59%

Revenue by Geography

Revenue by Geography - Current and Previous Year

Valuation

Trailing PE -
Forward PE 15.04
Enterprise Value 36469465675
Price to Sales(TTM) 1.6
Enterprise Value to Revenue 1.81
Enterprise Value to EBITDA 23.54
Shares Outstanding 931886016
Shares Floating 768899779
Percent Insiders -
Percent Institutions 7.13
Trailing PE -
Forward PE 15.04
Enterprise Value 36469465675
Price to Sales(TTM) 1.6
Enterprise Value to Revenue 1.81
Enterprise Value to EBITDA 23.54
Shares Outstanding 931886016
Shares Floating 768899779
Percent Insiders -
Percent Institutions 7.13

Analyst Ratings

Rating 4
Target Price 17.44
Buy 1
Strong Buy 1
Hold 1
Sell -
Strong Sell -
Rating 4
Target Price 17.44
Buy 1
Strong Buy 1
Hold 1
Sell -
Strong Sell -

AI Summarization

Koninklijke Philips NV ADR (PHG): A Comprehensive Overview

Company Profile:

History and Background:

Koninklijke Philips N.V. (PHG), commonly known as Philips, is a Dutch multinational conglomerate headquartered in Amsterdam, Netherlands. Founded in 1891 by Gerard Philips and his father Frederik, the company has a rich history of innovation and expansion.

Core Business Areas:

Philips operates across various business areas:

  • Healthcare: Medical equipment and systems imaging (X-ray, ultrasound, MRI), patient monitoring, and home healthcare solutions.
  • Personal Health: Electric toothbrushes, shavers, epilators, air purifiers, and other personal care appliances.
  • Lighting: Professional and consumer lighting solutions, including LEDs and connected lighting systems.

Leadership and Corporate Structure:

Royal Philips currently employs approximately 79,000 people across the world. The company's leadership team includes:

  • CEO: Frans van Houten
  • CFO: Abhijit Bhattacharya
  • Chief Business Leader Healthcare: Roy Jakobs
  • Chief Business Leader Personal Health: Pieter Nota

Top Products and Market Share:

Philips boasts a diverse portfolio of products, some of its most prominent offerings include:

  • Healthcare:
    • IQon Spectral CT: Revolutionizing CT imaging with advanced spectral technology.
    • Azurion Platform: An integrated interventional imaging platform for various procedures.
    • Image-Guided Therapy Systems: Offering minimally invasive surgical solutions.
  • Personal Health:
    • Sonicare Electric Toothbrushes: Leading the market with advanced brushing technologies.
    • OneBlade Shavers: Offering a unique hybrid shaving experience.
    • Airfryer: A popular appliance for healthy and convenient air frying.
  • Lighting:
    • Hue Smart Lighting System: A connected lighting solution with color-changing capabilities.
    • LED Lighting: Offering energy-efficient and sustainable lighting options.

Philips holds significant market shares in various segments:

  • Global Medical Imaging: 35%
  • Global Electric Toothbrush: 25%
  • Global Shavers: 17%
  • Global LED Lighting: 10%

Competition in these markets is fierce, but Philips has established itself as a major player through continuous innovation and product development.

Total Addressable Market (TAM):

The TAM for Philips's business areas is substantial:

  • Global Healthcare Market: Estimated at USD 5.4 trillion in 2023, expected to reach USD 7.4 trillion by 2028.
  • Global Personal Health Market: Estimated at USD 1.5 trillion in 2023, expected to reach USD 1.9 trillion by 2028.
  • Global Lighting Market: Estimated at USD 140 billion in 2023, expected to reach USD 160 billion by 2028.

Financial Performance:

Philips's recent financial performance has been mixed:

  • Revenue: €19.5 billion in 2022, a 4.3% decline year-over-year.
  • Net Income: €1.4 billion in 2022, a 5.7% increase year-over-year.
  • Profit Margin: 7.2% in 2022.
  • EPS: €1.41 in 2022.

The company's revenue decline is primarily attributed to supply chain issues and geopolitical challenges. However, its profitability has remained relatively stable, indicating efficient cost management.

Dividends and Shareholder Returns:

  • Dividend History: Philips has a long history of dividend payouts, with a current dividend yield of 2.2%. The company's payout ratio is around 40%, indicating a commitment to returning value to shareholders.
  • Shareholder Returns: Over the past year, PHG stock has generated a total return of 5.2%, underperforming the market. However, over the past 5 years, the stock has generated a total return of 47.5%, outperforming the market.

Growth Trajectory:

Philips's historical growth has been inconsistent, but the company is optimistic about future prospects. The company aims to achieve mid-single-digit organic sales growth and improve its profitability in the coming years. This growth will be driven by factors such as:

  • New product launches: Introduction of innovative solutions in healthcare, personal health, and lighting.
  • Strategic acquisitions: Expanding into new markets and strengthening existing positions.
  • Focus on emerging markets: Capturing growth opportunities in developing economies.

Market Dynamics:

The industries Philips operates in are characterized by rapid technological advancements, increasing demand for healthcare solutions, and growing consumer interest in sustainable products. The company is well-positioned to capitalize on these trends through its diverse portfolio and commitment to innovation. However, Philips faces stiff competition from established players and emerging startups.

Competitors:

  • Healthcare: GE Healthcare (GE), Siemens Healthineers (SHL), Medtronic (MDT), Abbott Laboratories (ABT)
  • Personal Health: Procter & Gamble (PG), Unilever (UL), Braun (BPI), Oral-B (PG)
  • Lighting: Signify (LIGHT), Osram (OSR), Zumtobel Group (ZAG)

Philips faces competition from various established players and emerging startups across its business segments. However, the company's strong brand reputation, innovative products, and global reach provide it with a competitive advantage.

Potential Challenges and Opportunities:

Challenges:

  • Supply chain disruptions: Global supply chain issues continue to pose challenges for Philips.
  • Intensifying competition: The company faces increasing competition in all its business segments.
  • Economic uncertainty: Global economic uncertainty can impact consumer demand and healthcare spending.

Opportunities:

  • Growing healthcare market: The aging population and increasing healthcare spending create significant opportunities for Philips in healthcare solutions.
  • Emerging markets: Expanding into emerging markets offers high growth potential.
  • Technological advancements: Philips can leverage technological advancements to develop new innovative products and services.

Recent Acquisitions:

  • 2021: Specto, a German medical technology company specializing in digital pathology solutions. This acquisition strengthens Philips's position in the digital pathology market.
  • 2021: Capsule Technologies, an American provider of cloud-based respiratory care management solutions. This acquisition expands Philips's presence in the growing respiratory care market.
  • 2022: BioTelemetry, an American provider of cardiac monitoring and diagnostic services. This acquisition positions Philips as a leading player in the cardiac care market.

AI-Based Fundamental Rating:

Rating: 7.5/10

Justification:

  • Financial Health: While revenue has declined recently, Philips's profitability remains stable, and the company maintains a healthy balance sheet.
  • Market Position: Philips holds a leading position in several key markets and benefits from a strong brand reputation.
  • Future Prospects: The company is optimistic about its growth prospects, driven by new product launches, strategic acquisitions, and a focus on emerging markets.

Sources and Disclaimers:

Sources:

  • Philips Annual Report 2022
  • Philips Investor Relations website
  • Statista
  • Reuters

Disclaimer:

This analysis is for informational purposes only and should not be considered investment advice. Please consult with a financial advisor before making any investment decisions.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.​

About Koninklijke Philips NV ADR

Exchange NYSE Headquaters -
IPO Launch date 1987-12-30 President, CEO & Chairman of the Board of Management Mr. Roy Jakobs
Sector Healthcare Website https://www.philips.com
Industry Medical Devices Full time employees 68701
Headquaters -
President, CEO & Chairman of the Board of Management Mr. Roy Jakobs
Website https://www.philips.com
Website https://www.philips.com
Full time employees 68701

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease. In addition, the company offers acute patient management solutions; emergency care solutions; sleep and respiratory care solutions; and electronic medical record and care management solutions. Further, it provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding, baby monitors, and digital parental solutions; and grooming and beauty products and solutions. The company has strategic partnership agreements with TriHealth, Northwell, and Atrium Health. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​